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While studying the effects of diphenylpiperazine calcium chan­
nel blockers on gastrointestinal functions it was found that flunari-
zine prevents gastric damage caused by different ulcerating 
agents (1). As most of the pro-ulcerogenic mechanisms including 
gastric wall hypercontractility, increased acid production, gastric 
wall microcirculation disorders, increased release of monoamines 
from mastocytes are calcium dependent (2) it is conceivable that cal ­
cium channel blockers, in particular flunarizine, could diminish gas­
tric lesions by influening one or more of these processes. The 
purpose of the present series of experiments was to determine the 
effect of flunarizine on contractility of smooth muscle strips obtained 
from antrum and fundus regions of guinea pig. stomach and to ex­
plain the possible connection with the previously established ucero-
protective effect of this drug. Male guinea pig weighing 300-400 g 
were killed by shooting and bleeding. The stomach was removed im­
mediately. Circular muscle strips (2 mm wide and 10 mm long, mu­
cosa removed using blunt dissection) were prepared from antrum or 
fundus regions. Muscle strips were placed in organ bath (10ml in ca ­
pacity) filled with Krebs solution (up to 2 strips were suspended in 
the same organ bath). Mechanical activity was recorded under 
isometric conditions. Initial tension (1g) was applied to each prep­
aration and tissues were allowed to adapt for a 60 min period before 
testing. The effects of flunarizine on phasic antral activity and tonic 
fundal activity were studied. For this purpose normal Krebs solution 
as well as Krebs solution with high К + , C a 2 + or Ba 2 + concentrat ion 
were used. Flunarizine (Pharmachim) was added directly to the organ 
bath in increasing concentrations from 5.10 up to 5.10 M/l. The-
mechanical activity was measured in mm and the percentage of the 
contractile response in the percents of flunarizine towards the spon­
taneous contractile response was calculated. The Krebs solution had 
the following composition in mM/l: N a + 137; K + 5,9; Ca 2,5; 
Mg2 + 1,2; Cf 124; НСОз" 25; H2PO4" 1,2; glucose 11,5; equilibrated 
with 95% O2 and 5% CO2 at 36°C, pH 7,4. As shown in fig. 1 flunari­
zine produced a concentration-related decrease in the spontaneous 
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phasic activity of antrum while the tonic reaction of the fundus per­
sisted, only slightly reduced in size. The latter can be selectively sup­
pressed by nitroprusside sodium. When concentrations of Са + or 
B a 2 + in Krebs solution were increased the effect of flunarizine on 
phasic activity was significantly reduced (fig. 2). Fig. 3 shows that 
flunatizine is potent in reducing high-K + evoked contraction both in 
antrum and fundus. These data are in good agreement with the re­
sults obtained about the effects of other calcium channel bloc­
kers (3). These data indicate that the ability of flunarizine to reduce 
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the spontaneous phasic antral 
without affecting tonic fundal 
activity could be in relation with 
the previously established ul-
ceroprotective properties of this 
drug. Other calcium channel 
blockers (nifedipine, verapamil) 
that can alter gastric contrac­
tility in similar way have been 
found to possess protective ef­
fect against gastric mucosal 
damage (2,4,5). 
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